BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16113329)

  • 41. Infection with arginase-deficient Leishmania major reveals a parasite number-dependent and cytokine-independent regulation of host cellular arginase activity and disease pathogenesis.
    Muleme HM; Reguera RM; Berard A; Azinwi R; Jia P; Okwor IB; Beverley S; Uzonna JE
    J Immunol; 2009 Dec; 183(12):8068-76. PubMed ID: 19923451
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites.
    Badirzadeh A; Taheri T; Taslimi Y; Abdossamadi Z; Heidari-Kharaji M; Gholami E; Sedaghat B; Niyyati M; Rafati S
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005774. PubMed ID: 28708893
    [TBL] [Abstract][Full Text] [Related]  

  • 43. IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice.
    Bronte V; Serafini P; De Santo C; Marigo I; Tosello V; Mazzoni A; Segal DM; Staib C; Lowel M; Sutter G; Colombo MP; Zanovello P
    J Immunol; 2003 Jan; 170(1):270-8. PubMed ID: 12496409
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Murine Susceptibility to
    Tomiotto-Pellissier F; Miranda-Sapla MM; Silva TF; Bortoleti BTDS; Gonçalves MD; Concato VM; Rodrigues ACJ; Detoni MB; Costa IN; Panis C; Conchon-Costa I; Bordignon J; Pavanelli WR
    Front Cell Infect Microbiol; 2021; 11():687633. PubMed ID: 34660334
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resolution of Cutaneous Leishmaniasis and Persistence of
    Paduch K; Debus A; Rai B; Schleicher U; Bogdan C
    J Immunol; 2019 Mar; 202(5):1453-1464. PubMed ID: 30665936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Age-related alteration of arginase activity impacts on severity of leishmaniasis.
    Müller I; Hailu A; Choi BS; Abebe T; Fuentes JM; Munder M; Modolell M; Kropf P
    PLoS Negl Trop Dis; 2008 May; 2(5):e235. PubMed ID: 18478052
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunohistochemical evidence of stress and inflammatory markers in mouse models of cutaneous leishmaniosis.
    Araujo AP; Giorgio S
    Arch Dermatol Res; 2015 Oct; 307(8):671-82. PubMed ID: 25896942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Th1/Th2-regulated arginase availability modulates Leishmania infection.
    Taylor-Robinson A
    Trends Parasitol; 2001 Jun; 17(6):262. PubMed ID: 11378016
    [No Abstract]   [Full Text] [Related]  

  • 49. Arginase and its mechanisms in Leishmania persistence.
    Pessenda G; da Silva JS
    Parasite Immunol; 2020 Jul; 42(7):e12722. PubMed ID: 32294247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Crystal structure of arginase from Leishmania mexicana and implications for the inhibition of polyamine biosynthesis in parasitic infections.
    D'Antonio EL; Ullman B; Roberts SC; Dixit UG; Wilson ME; Hai Y; Christianson DW
    Arch Biochem Biophys; 2013 Jul; 535(2):163-76. PubMed ID: 23583962
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LmjF.22.0810 from
    Vacas A; Fernández-Rubio C; Larrea E; Peña-Guerrero J; Nguewa PA
    Biomedicines; 2020 Oct; 8(11):. PubMed ID: 33114674
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhancer-mediated control of macrophage-specific arginase I expression.
    Pauleau AL; Rutschman R; Lang R; Pernis A; Watowich SS; Murray PJ
    J Immunol; 2004 Jun; 172(12):7565-73. PubMed ID: 15187136
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Arginase: an emerging key player in the mammalian immune system.
    Munder M
    Br J Pharmacol; 2009 Oct; 158(3):638-51. PubMed ID: 19764983
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protein energy malnutrition increases arginase activity in monocytes and macrophages.
    Corware K; Yardley V; Mack C; Schuster S; Al-Hassi H; Herath S; Bergin P; Modolell M; Munder M; Müller I; Kropf P
    Nutr Metab (Lond); 2014; 11(1):51. PubMed ID: 25392710
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elementary Effect of Arginase in the Weight Physiology of the Mouse.
    Irons WG; Wiswell OB
    Science; 1947 Oct; 106(2756):393-4. PubMed ID: 17750560
    [No Abstract]   [Full Text] [Related]  

  • 56.
    Oljuskin T; Azodi N; Volpedo G; Bhattacharya P; Markle HL; Hamano S; Matlashewski G; Satoskar AR; Gannavaram S; Nakhasi HL
    iScience; 2023 Sep; 26(9):107593. PubMed ID: 37744403
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibiting Human and
    Assouab A; El Filaly H; Akarid K
    Trop Med Infect Dis; 2022 Nov; 7(12):. PubMed ID: 36548655
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Eosinophils, but Not Type 2 Innate Lymphoid Cells, Are the Predominant Source of Interleukin 4 during the Innate Phase of
    Sasse C; Barinberg D; Obermeyer S; Debus A; Schleicher U; Bogdan C
    Pathogens; 2022 Jul; 11(8):. PubMed ID: 35894051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Flow Cytometric Characterization of Macrophages Infected
    Brigo N; Pfeifhofer-Obermair C; Demetz E; Tymoszuk P; Weiss G
    Bio Protoc; 2022 Jun; 12(11):e4440. PubMed ID: 35799903
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polyamine Metabolism in
    Carter NS; Kawasaki Y; Nahata SS; Elikaee S; Rajab S; Salam L; Alabdulal MY; Broessel KK; Foroghi F; Abbas A; Poormohamadian R; Roberts SC
    Med Sci (Basel); 2022 Apr; 10(2):. PubMed ID: 35645240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.